市場調査レポート

商品コード

1619350

細胞表面マーカーの市場規模・シェア・成長分析 (製品別、供給源別、用途別、地域別)：産業予測 (2024～2031年)

Cell Surface Markers Market Size, Share, Growth Analysis, By Product (Antibody, PCR Array), By Source (Human, Mouse), By Application, By Region - Industry Forecast 2024-2031

出版日: 2024年12月20日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 778,146円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 910,284円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,042,422円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.82円

全表示
概要
目次

概要

サンプル依頼リストに入れる

細胞表面マーカーの世界市場規模は、2022年に279億米ドルと評価され、2023年の301億3,000万米ドルから2031年には557億7,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは8.0％で成長する見通しです。

世界の細胞表面マーカー市場は、医学研究、診断法、医薬品開発における重要な役割によって力強い成長を遂げています。一般に細胞表面抗原またはCDマーカーと呼ばれるこれらのタンパク質は、様々な細胞集団を同定・分離し、細胞機能や疾病メカニズムの理解を深める上で極めて重要です。主な市場促進要因としては、慢性疾患の罹患率の上昇、個別化医療の推進力の高まり、フローサイトメトリーや細胞分析技術の進歩などが挙げられます。腫瘍学、免疫学、感染症における用途の拡大も、市場の勢いにさらに貢献しています。しかし、高い装置コストや複雑な分析などの課題が潜在的な成長を制限しています。それでも、マルチプレックス・プラットフォームやハイスループット・プラットフォームにおける技術革新が、市場の進化に有望な機会を提供しています。

北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主要企業が採用した戦略
市場の近年の動向
主要企業の市場シェア（2023年）
主要企業のプロファイル
- 企業概要
- 製品ポートフォリオ分析
- セグメント別シェア分析
- 収益の前年比比較 (2021～2023年)

主要企業のプロファイル

Abbott Laboratories
Beckman Coulter Inc.（Danaher Corporation）
Becton, Dickinson and Company（BD）
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche Ltd
Grifols SA
Immucor Inc.
Nihon Kohden Corporation
Thermo Fisher Scientific Inc.
Siemens Healthineers
Sysmex Corporation
QIAGEN NV
Agilent Technologies Inc.
Luminex Corporation（DiaSorin SpA）
Miltenyi Biotec
Novus Biologicals
Cell Signaling Technology（CST）
Stemcell Technologies
Fluidigm Corporation（Standard BioTools）

結論と推奨事項

Product Code: SQMIG35J2099

Global Cell Surface Markers Market size was valued at USD 27.9 billion in 2022 and is poised to grow from USD 30.13 billion in 2023 to USD 55.77 billion by 2031, growing at a CAGR of 8.0% during the forecast period (2024-2031).

The global cell surface markers market is witnessing robust growth, driven by their essential role in medical research, diagnostic practices, and drug development. These proteins, commonly referred to as cell surface antigens or CD markers, are critical for identifying and isolating various cell populations, enhancing the understanding of cellular functions and disease mechanisms. Key market drivers include the rising incidence of chronic diseases, an increasing push for personalized medicine, and advancements in flow cytometry and cell analysis technologies. Expanding applications in oncology, immunology, and infectious diseases further contribute to market momentum. However, challenges like high instrument costs and complex analysis limit potential growth. Yet, innovations in multiplexed and high-throughput platforms present promising opportunities for the market's evolution.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Surface Markers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Surface Markers Market Segmental Analysis

Global Cell Surface Markers Market is segmented by product, source, application, end user and region. Based on product, the market is segmented into antibody and PCR array. Based on source, the market is segmented into human, mouse, rat and others. Based on application, the market is segmented into research and clinical. Based on end user, the market is segmented into research institutes and pharmaceutical & biotechnology industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Cell Surface Markers Market

A significant factor propelling the global cell surface markers market is the rising prevalence of chronic diseases. As conditions such as cancer, cardiovascular diseases, and autoimmune disorders become more common, there is a growing need for effective diagnostic and therapeutic tools. Cell surface markers are essential in diagnosing, prognosticating, and enabling targeted treatments, thus playing a pivotal role in personalized medicine. The increasing burden of these persistent health issues across the globe intensifies the demand for advanced cell analysis methodologies, consequently driving growth in the market for cell surface markers. This trend underscores the critical importance of these markers in modern healthcare.

Restraints in the Global Cell Surface Markers Market

One of the primary obstacles faced by the global cell surface markers market is the substantial expense associated with advanced cell analysis instruments and methodologies. The acquisition and ongoing maintenance of complex flow cytometers, hematology analyzers, and other sophisticated analytical platforms can incur significant financial investment. Furthermore, the costs linked to reagents and kits essential for cell surface marker analysis can also be quite high. This financial burden not only restricts the accessibility and adoption of advanced cell analysis technologies, particularly in resource-limited settings and emerging economies but also hinders overall market growth, especially in regions with budget-sensitive healthcare systems.

Market Trends of the Global Cell Surface Markers Market

The global cell surface markers market is experiencing a significant trend towards personalized medicine, significantly influencing its growth dynamics. As healthcare transitions to more tailored therapeutic approaches, the focus on identifying and analyzing cell surface markers has intensified. These markers are critical for discerning specific cell populations, which in turn informs the efficacy of targeted therapies. With advancements in technology facilitating sophisticated cell analysis and detection methods, there is a burgeoning demand for tailored treatments based on an individual's unique cell surface marker profile. This shift towards customization not only enhances treatment outcomes but also propels innovation across the cell surface markers market.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2023
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Technological Advancement

Global Cell Surface Markers Market Size by Product & CAGR (2024-2031)

Market Overview
Antibody
PCR Array

Global Cell Surface Markers Market Size by Source & CAGR (2024-2031)

Market Overview
Human
Mouse
Rat
Others

Global Cell Surface Markers Market Size by Application & CAGR (2024-2031)

Market Overview
Research
Clinical

Global Cell Surface Markers Market Size by End User & CAGR (2024-2031)

Market Overview
Research Institutes
Pharmaceutical & Biotechnology Industry

Global Cell Surface Markers Market Size & CAGR (2024-2031)

North America (Product, Source, Application, End User)
- USA
- Canada
Europe (Product, Source, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Source, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Source, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Source, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2023
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beckman Coulter Inc. (Danaher Corporation)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols SA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Immucor Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nihon Kohden Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN NV
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (DiaSorin SpA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novus Biologicals
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cell Signaling Technology (CST)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stemcell Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (Standard BioTools)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

細胞表面マーカーの市場規模・シェア・成長分析 (製品別、供給源別、用途別、地域別)：産業予測 (2024～2031年)

Cell Surface Markers Market Size, Share, Growth Analysis, By Product (Antibody, PCR Array), By Source (Human, Mouse), By Application, By Region - Industry Forecast 2024-2031

目次

イントロダクション

分析手法

エグゼクティブサマリー

市場力学と展望

市場の主な考察

世界の細胞表面マーカーの市場規模・CAGR：製品別 (2024～2031年)

世界の細胞表面マーカーの市場規模・CAGR：供給源別 (2024～2031年)

世界の細胞表面マーカーの市場規模・CAGR：用途別 (2024～2031年)

世界の細胞表面マーカーの市場規模・CAGR：エンドユーザー別 (2024～2031年)

世界の細胞表面マーカーの市場規模・CAGR (2024～2031年)